Medical Management of Caries in the Primary Dentition Using Silver Nitrate

July 9, 2019 updated by: Arwa Owais

Medical Management of Caries in the Primary Dentition Using Silver Nitrate: A Pilot Study

This pilot trial compares conventional restorations with a new strategy based on the medical management of caries using silver nitrate and fluoride varnish with no restorations.

Study Overview

Detailed Description

This is a two-arm, parallel group, patient-randomized controlled pilot trial. Children with at least one primary tooth where caries extends into dentine. Children will be randomized and treated according to one of two treatment approaches;(1) conventional caries management with best practice prevention, or (2) medical management of caries using silver nitrate with best practice prevention.

Baseline measures and outcome data (at treatment/review during two year follow-up) are assessed through direct reporting, clinical examination including blinded radiographic assessment, and child/parent questionnaires.

Study Type

Interventional

Enrollment (Actual)

122

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 7 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Presense of one or more cavitated carious lesions in the primary dentition, extending into dentin but not encroaching on the pulp.
  • Absense of any spontaneous or elicited pain due to caries, or signs of pulpal infection in response to any of the carious lesions in the primary dentition to be included in the study

Exclusion Criteria:

  • Hereditary developmental defects of the teeth such as Amelogenesis Imperfecta and Dentinogenesis Imperfecta
  • Medical conditions that prevent treatment of the child in the outpatient clinic. These conditions include severe bleeding disorders, cardiac problems and mental disabilities that prevent child from communication with the research team.
  • Known allergy/sensitivity to any of the dental materials.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: conventional treatment group
The child will receive a prophylaxis and fluoride varnish. Parents will fill out a parent and a child questionnaire.
A dental prophylaxis is a cleaning procedure performed to thoroughly clean the teeth. Prophylaxis is an important dental treatment for halting the progression of periodontal disease and gingivitis.
Other Names:
  • Prophy
Fluoride varnish is a highly concentrated form of fluoride which is applied to the tooth's surface, by a dentist, dental hygienist or other health care professional, as a type of topical fluoride therapy.
Other Names:
  • Fluoride
Other: Silver Nitrate group
The child will receive a prophylaxis, then silver nitrate and then fluoride varnish. Parents will fill out a parent and a child questionnaire.
A dental prophylaxis is a cleaning procedure performed to thoroughly clean the teeth. Prophylaxis is an important dental treatment for halting the progression of periodontal disease and gingivitis.
Other Names:
  • Prophy
Fluoride varnish is a highly concentrated form of fluoride which is applied to the tooth's surface, by a dentist, dental hygienist or other health care professional, as a type of topical fluoride therapy.
Other Names:
  • Fluoride
a small amount will be applied to the tooth via a cotton applicator. Silver nitrate is a colorless, odorless, transparent solution used as an escharotic, dehydrating and sclerosing agent.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in baseline Caries Experience and activity (Incidence of caries in primary teeth)
Time Frame: through study completion, for 2 years
Detailed measurements of caries experience will be recorded at baseline and annual caries examination using EC4
through study completion, for 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caries activity in primary teeth
Time Frame: through study completion, for 2 years
Detailed measurements of caries activity will be recorded at baseline and annual caries examination using Nyvad scores.
through study completion, for 2 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain (toothache) and/or infection in primary teeth
Time Frame: through study completion, for 2 years
Assessments for pain from toothache will be made at each visit throughout the patient's participation in the trial using the Dental Discomfort Questionnaire completed by the parents.
through study completion, for 2 years
Patient quality of life
Time Frame: through study completion, for 2 years
Quality of life will be assessed through direct reporting by parents and children about pain and related activities
through study completion, for 2 years
Cost-effectiveness
Time Frame: through study completion, for 2 years
Cost-effectiveness for both groups will be calculated and compared
through study completion, for 2 years
Acceptability of treatment strategies by parents and children
Time Frame: through study completion, for 2 years
Acceptability is checked throughout the whole period of the study every time the patient comes in for a recall
through study completion, for 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Arwa I Owais, BDS, MS, Associate Profesor in Pediatric Dentistry
  • Principal Investigator: MIchael Kanellis, DDS, MS, Professor in Pediatric Dentistry & Dean for Patient Cares

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (Actual)

August 24, 2017

Study Completion (Actual)

August 21, 2018

Study Registration Dates

First Submitted

October 28, 2015

First Submitted That Met QC Criteria

November 10, 2015

First Posted (Estimate)

November 13, 2015

Study Record Updates

Last Update Posted (Actual)

July 11, 2019

Last Update Submitted That Met QC Criteria

July 9, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dental Caries

Clinical Trials on Prophylaxis

Subscribe